Resilience Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Out of Business

Resilience Therapeutics General Information

Description

Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditions including PTSD and Social Anxiety Disorder. The company is focused on developing therapeutics that provide both symptom relief and potential disease modification for PTSD and other Stress-Related Disorders, providing medical practitioners with first-in-class therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Boston, MA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Boston, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resilience Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 31-Dec-2021 Completed Out of Business
2. Seed Round 03-Mar-2016 Completed Generating Revenue
1. Seed Round 30-Jul-2015 $2.92M $2.92M Completed Generating Revenue
To view Resilience Therapeutics’s complete valuation and funding history, request access »

Resilience Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Resilience Therapeutics’s complete cap table history, request access »

Resilience Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditi
Drug Discovery
Boston, MA
8 As of 2016

San Diego, CA
 

Chatham, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Resilience Therapeutics Competitors (43)

One of Resilience Therapeutics’s 43 competitors is Neurelis, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurelis Venture Capital-Backed San Diego, CA
Tonix Pharmaceuticals Holding Corporation Chatham, NJ
NeuroNascent Venture Capital-Backed Clarksville, MD
Neurogene Formerly VC-backed New York, NY
LeonaBio Formerly VC-backed Bothell, WA
You’re viewing 5 of 43 competitors. Get the full list »

Resilience Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resilience Therapeutics FAQs

  • When was Resilience Therapeutics founded?

    Resilience Therapeutics was founded in 2015.

  • Where is Resilience Therapeutics headquartered?

    Resilience Therapeutics is headquartered in Boston, MA.

  • What is the size of Resilience Therapeutics?

    Resilience Therapeutics has 8 total employees.

  • What industry is Resilience Therapeutics in?

    Resilience Therapeutics’s primary industry is Drug Discovery.

  • Is Resilience Therapeutics a private or public company?

    Resilience Therapeutics is a Private company.

  • What is Resilience Therapeutics’s current revenue?

    The current revenue for Resilience Therapeutics is .

  • How much funding has Resilience Therapeutics raised over time?

    Resilience Therapeutics has raised $3.42M.

  • Who are Resilience Therapeutics’s competitors?

    Neurelis, Tonix Pharmaceuticals Holding, NeuroNascent, Neurogene, and LeonaBio are some of the 43 competitors of Resilience Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process